These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 10767724

  • 1. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA, Harmon BV, Cameron DP, Allan DJ.
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [Abstract] [Full Text] [Related]

  • 2. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY, Singh B.
    J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
    [Abstract] [Full Text] [Related]

  • 3. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
    O'Brien BA, Harmon BV, Cameron DP, Allan DJ.
    J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
    [Abstract] [Full Text] [Related]

  • 4. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
    Jiang TJ, Zhou ZG, Su H.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.
    Augstein P, Elefanty AG, Allison J, Harrison LC.
    Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948
    [Abstract] [Full Text] [Related]

  • 6. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
    Takahashi K, Satoh J, Sagara M, Zhu XP, Muto G, Muto Y, Fukuzawa M, Nishimura S, Miyaguchi S, Toyata T.
    J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
    [Abstract] [Full Text] [Related]

  • 7. Immunolocalization of monocyte chemoattractant protein-1 in islets of NOD mice during cyclophosphamide administration.
    Reddy S, Bai Y, Robinson E, Ross J.
    Ann N Y Acad Sci; 2006 Oct; 1079():103-8. PubMed ID: 17130538
    [Abstract] [Full Text] [Related]

  • 8. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor.
    Nicoletti F, Di Marco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Meroni P.
    Eur J Immunol; 1994 Aug; 24(8):1843-7. PubMed ID: 8056041
    [Abstract] [Full Text] [Related]

  • 9. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F, Yu M, Zhu Q.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of nicotinamide on experimental induced diabetes.
    Alenzi FQ.
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):11-8. PubMed ID: 19279354
    [Abstract] [Full Text] [Related]

  • 12. [Mechanisms of human glutamic acid decarboxylase 65 DNA vaccine preventing diabetes in non-obese diabetic mice].
    Luo JH, Zhou ZG, Jiang TJ, Pei JH, Li X, He L, Sun SG.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 02; 84(21):1791-5. PubMed ID: 15631776
    [Abstract] [Full Text] [Related]

  • 13. Prevention of cyclophosphamide-induced accelerated diabetes in the NOD mouse by nicotinamide or a soy protein-based infant formula.
    Reddy S, Karanam M, Robinson E.
    Int J Exp Diabetes Res; 2001 Nov 02; 1(4):299-313. PubMed ID: 11467420
    [Abstract] [Full Text] [Related]

  • 14. Early nicotinamide treatment in the NOD mouse: effects on diabetes and insulitis suppression and autoantibody levels.
    Reddy S, Bibby NJ, Elliott RB.
    Diabetes Res; 1990 Oct 02; 15(2):95-102. PubMed ID: 2151892
    [Abstract] [Full Text] [Related]

  • 15. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
    Mori Y, Kato T, Kodaka T, Kanagawa EM, Hori S, Kanagawa O.
    Int Immunol; 2008 Sep 02; 20(9):1231-7. PubMed ID: 18644830
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.
    Nicoletti F, Zaccone P, Di Marco R, Magro G, Grasso S, Morrone S, Santoni A, Tempera G, Meroni PL, Bendtzen K.
    Immunology; 1995 Aug 02; 85(4):645-50. PubMed ID: 7558161
    [Abstract] [Full Text] [Related]

  • 18. In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice.
    Mahiou J, Walter U, Lepault F, Godeau F, Bach JF, Chatenoud L.
    J Autoimmun; 2001 Jun 02; 16(4):431-40. PubMed ID: 11437491
    [Abstract] [Full Text] [Related]

  • 19. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
    Piercy V, Toseland CD, Turner NC.
    Metabolism; 2000 Dec 02; 49(12):1548-54. PubMed ID: 11145115
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
    Reimers JI.
    Dan Med Bull; 1998 Apr 02; 45(2):157-80. PubMed ID: 9587701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.